2000-21年英国妊娠期自身免疫性疾病患病率趋势:一项回顾性队列研究
基于英国两个大型数据库的回顾性队列研究纳入5 165 960次妊娠,分析17种自身免疫病患病率。17种自身免疫病合并患病率从2000年3.5%(6058/172430)升至2021年4.7%(8429/181532),银屑病患病率最高,桥本甲状腺炎上升最陡。较不贫困地区女性、既往吸烟者、≥5次妊娠者及合并代谢或精神疾病者自身免疫病风险更高。
要点
- 17种自身免疫病合并患病率从2000年3.5%升至2021年4.7%。
- 银屑病在整个研究期间患病率最高,桥本甲状腺炎上升最陡。
- 较不贫困地区女性自身免疫病风险更高(aOR 1.10,95%CI 1.07-1.14)。
核心结论
- 妊娠期自身免疫病负担日益加重,作者呼吁研究其对妊娠结局的影响。
- 作者认为卫生政策应解决专科护理缺口,确保患者获得循证照护以预防自身免疫病恶化和不良妊娠结局。
研究设计与样本
- 英国基于人群的回顾性队列研究,使用临床实践研究数据链Gold和Aurum两个大型数据库及相妊娠登记数据。
- 纳入2000年1月1日至2021年12月31日期间15-49岁育龄女性妊娠,计算17种自身免疫病年度患病率。
- 采用逻辑回归估计比值比,分析女性特征、合并症与自身免疫病的关系。
- 共纳入2 831 472名女性的5 165 960次妊娠;2000-21年间100 655名有自身免疫病编码诊断的女性共185 208次妊娠。
主要发现
- 17种自身免疫病合并患病率从2000年3.5%(6058/172430)升至2021年4.7%(8429/181532)。
- 银屑病在整个研究期间患病率最高;大多数自身免疫病患病率从2000年到2021年上升,桥本甲状腺炎上升最陡,其次为乳糜泻、Graves病和1型糖尿病。
- 较不贫困地区女性妊娠期自身免疫病比值比更高(aOR 1.10,95%CI 1.07-1.14);少数族裔患病率低于白人女性(黑人女性0.48,95%CI 0.45-0.51;亚裔女性0.81,95%CI 0.77-0.85)。
- 既往吸烟者自身免疫病比值比显著高于不吸烟者(1.20,95%CI 1.18-1.23);与单次妊娠女性相比,≥5次妊娠女性自身免疫病比值比显著更高(1.12,95%CI 1.10-1.15)。
- 合并代谢和精神疾病者妊娠期自身免疫病比值比显著更高:2型糖尿病1.41(95%CI 1.30-1.53)、高血压1.07(95%CI 1.01-1.13)、焦虑1.15(95%CI 1.12-1.19)、抑郁1.17(95%CI 1.14-1.20)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autoimmune diseases are increasingly prevalent worldwide and disproportionately affect women of reproductive age, including during pregnancy. Given the association between autoimmune diseases, comorbidities, and risk factors for adverse pregnancy outcomes, we aimed to estimate the burden of autoimmune disease in pregnancy. METHODS: This was a UK population-based retrospective cohort study using routinely collected data from two large databases (Clinical Practice Research Datalink Gold and Aurum) and associated pregnancy registers. Prevalence was calculated annually for 17 autoimmune diseases (Addison's disease, alopecia areata, ankylosing spondylitis, coeliac disease, inflammatory bowel disease (including Crohn's disease and ulcerative colitis), Graves' disease, Hashimoto's thyroiditis, multiple sclerosis, myasthenia gravis, psoriasis, psoriatic arthritis, rheumatoid arthritis, Sjögren's disease, SLE, systemic sclerosis, type 1 diabetes, and vitiligo) in pregnancies among women of reproductive age (15-49 years) from Jan 1, 2000, to Dec 31, 2021. Logistic regression was used to estimate odds ratios, describing the relationship between women's characteristics (age, ethnicity, deprivation, BMI, smoking status, and gravidity), comorbidities, and autoimmune diseases. Patient and public involvement and engagement representatives participated in formulating the research question. They also played key role in collaboration with clinicians and researchers to identify and consider the list of autoimmune diseases in the study, and played a key role in disseminating the results. FINDINGS: 5 165 960 pregnancies in 2 831 472 women were included. In 2000-21, there were 185 208 pregnancies in 100 655 women who had a coded diagnosis of autoimmune disease. There was an increase in prevalence of the combination of 17 autoimmune diseases, from 6058 (3·5%) of 172 430 in 2000 to 8429 (4·7%) of 181 532 in 2021. Of the 17 autoimmune diseases studied, psoriasis had the highest prevalence throughout the study period. The prevalence of most of the autoimmune diseases increased from 2000 to 2021. The steepest rise was Hashimoto's thyroiditis, followed by coeliac disease, Grave's disease, and type 1 diabetes. Women in less deprived areas had higher odds of an autoimmune disease during pregnancy (adjusted odds ratio 1·10 [95% CI 1·07-1·14]), whereas minority ethnic groups had lower prevalence rates compared with White women (Black women 0·48 [0·45-0·51]; Asian women 0·81 [0·77-0·85]). Ex-smokers had significantly higher odds of autoimmune disease than non-smokers (1·20 [1·18-1·23]). When compared with women with a single pregnancy, the odds of having an autoimmune disease were significantly higher for women with five or more pregnancies (1·12 [1·10-1·15]). Women with metabolic and mental health conditions had significantly higher odds of having an autoimmune disease during pregnancy (type 2 diabetes, 1·41 [1·30-1·53]; hypertension, 1·07 [1·01-1·13]; anxiety, 1·15 [1·12-1·19]; depression, 1·17 [1·14-1·20]). INTERPRETATION: The growing burden of autoimmune diseases in pregnancy calls for research into their impact on outcomes. Health policy should address gaps in specialised care to ensure individuals receive evidence-based care to prevent deterioration of the autoimmune disease and development of adverse pregnancy outcomes. FUNDING: Strategic Priority Fund, Medical Research Council, National Institute for Health and Care Research, Economic and Social Research Council, and Engineering and Physical Sciences Research Council.
引用
- Singh M, Phillips K, Wang J, et al. Trends in the prevalence of autoimmune diseases during pregnancy in the UK, 2000-21: a retrospective cohort study. Lancet Rheumatol. 2025. PMID: 40473454. doi:10.1016/S2665-9913(25)00039-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。